Comparing two pain management techniques for hip surgery
Anterior Iliopsoas Muscle Space Block Versus Supra-Iliac Anterior Quadratus Lumborum Block for Analgesia in Total Hip Arthroplasty: A Randomized Controlled Trial
This study is testing two different pain management techniques for people aged 50-80 who are having hip surgery to see which one helps them feel better and recover faster.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 72 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | Zagazig University Government |
| Locations | 1 site (Zagazig, Alsharqia) |
| Trial ID | NCT05556759 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to compare the effectiveness of two regional anesthetic techniques, the anterior iliopsoas muscle space block and the supra-iliac anterior quadratus lumborum block, in managing postoperative pain for patients undergoing total hip arthroplasty. The study will involve patients aged 50-80 years who are scheduled for elective hip surgery and will assess pain levels and recovery outcomes following the procedures. By utilizing these innovative analgesia methods, the trial seeks to enhance recovery and reduce complications associated with postoperative pain. The findings could lead to improved pain management strategies in hip arthroplasty.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 50-80 years with a BMI of 30 or less, who are scheduled for elective total hip arthroplasty.
Not a fit: Patients with a history of allergies to local anesthetics, bleeding disorders, or chronic pain conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve pain management and recovery times for patients undergoing hip surgery.
How similar studies have performed: Previous studies have shown promising results with regional anesthetic techniques in managing postoperative pain, indicating that this approach is both relevant and potentially beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient acceptance. * Age 50-80 years old. * BMI ≤ 30 kg/m2 * ASA I - III. * Elective total hip arthroplasty under general anesthesia. Exclusion Criteria: * History of allergy to the LA agents used in this study * Skin lesion at the needle insertion site, * Those with bleeding disorders, sepsis, liver disease, and psychiatric disorders * Pre-existing neurological deficit in the lower extremity * History of chronic pain and taking analgesics * History of cognitive dysfunction or mental illness
Where this trial is running
Zagazig, Alsharqia
- Faculty of medicine, zagazig university — Zagazig, Alsharqia, Egypt (Recruiting)
Study contacts
- Principal investigator: Shereen E Abd Ellatif, MD — Faculty of medicine, zagazig university
- Study coordinator: Shereen E Abd Ellatif, MD
- Email: shosh.again@gmail.com
- Phone: 01007948840
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.